Visiongain publishes Generic Drugs Market 2020-2030 report

Visiongain publishes Generic Drugs Market 2020-2030 report

PR Newswire

LONDON, Aug. 28, 2020

Growth in Leading Regional and National Markets (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico, Teva, Novartis, Mylan, Pfizer, Abbott, Sun Pharma, Aspen, Fresenius Kabi, Sanofi, Dr. Reddy's Laboratories Limited, Apotex)

LONDON, Aug. 28, 2020 /PRNewswire/ -- The global generic drugs market is estimated at US$xyz billion in 2020 and is projected to reach at a CAGR of xyz% during forecast period 2020-2030 to grow at a market value of US$xyz billion by 2030, taking into account assumptions for V-shaped economic conditions. The increase in healthcare expenditure and a rise in the cost of pharmaceuticals worldwide results in a strained national budget due to which a high proportion of people are not able to access to essential medications. As per the World Health Organization (WHO), approximately 30% of the world's population lack access to essential medicines. The main factor that hampers access to these medicines is the cost of these pharmaceutical drugs. The robust growth of the pharmaceutical market and increase in the share of total healthcare spending have reignited the age-old debate on how to balance the cost of innovation in drug research and grant universal access to that research.

Visiongain Logo

Reduction in healthcare expenditure by generic medicines has been acknowledged for a long time. Multiple studies have proven that substituting the brand name drugs with cheaper generic medicines can prove to save about 10-90% of the cost spent on the preparation of these medicines. Government initiatives like reimbursement policies have further encouraged the use of generic drugs and this policy has led the adoption of using generic medicines as a substitute over expensive branded original medications by various healthcare systems.

This Visiongain report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today. To access the data contained in this document please email contactus@visiongain.com

To request sample pages from this report please email contactus@visiongain.com or refer to our website: https://www.visiongain.com/report/generic-drugs-market-report-2020-2030/

Market Driving Forces

• Emerging market: This factor has a direct link with the growth of the geographical generic drug market. So, with the emergence of new generic markets, the competition for generic drugs is increasing because of which various regions and companies are competing to increase their sales of generic drugs in the market.

• Awareness and advance healthcare systems: Earlier, people, as well as the doctors, were not quite aware of the use of generic drugs but after the introduction of generic drugs, companies and organizations have come up with workshops, conferences and training to promote the idea of generic drugs so that, people could be well-aware of its use.

• Cost-effectiveness and increasing investments: The cost of generic drugs is quite cheap as compared to the brand-name drugs which have increased the sales of generic drugs in the market. As the cost of these drugs is affordable so, many companies have started investing in manufacturing the generic drugs.

• Increase of chronic diseases and the ageing population: This is one of the most important factors that contribute to driving the sales of generic drugs.

How this report will benefit you

In this brand new 431-page report you will receive 66 tables and 287 figures– all unavailable elsewhere.

The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market. By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Generic Drugs Market by Drug Delivery forecasts from 2020-2030

• Oral

• Dermal/Topical

• Inhalants

• Injectable

• Generic Drugs Market by Distribution Channel forecasts from 2020-2030

• Hospital Pharmacy

• Retail Pharmacy

Generic Drugs Market by Application forecasts from 2020-2030

• Oncology

• Diabetes

• Autoimmune

• Other Application

• Generic Drugs Market forecasts from 2020-2030 by Regional and National Market:

North America: U.S., Canada

Europe: Germany, France, UK, Italy, Spain, Rest of Europe

Asia-Pacific: Japan, China, Australia, South Korea, India, Rest of Asia-Pacific

Middle East & Africa: South Africa, Saudi Arabia, UAE, Rest of Middle east & Africa

Latin America: Brazil, Argentina, Mexico, Rest of Latin America

The global generic drugs market is estimated at US$xyz billion in 2020 and is projected to reach at a CAGR of xyz% during forecast period 2020-2030 to grow at a market value of US$xyz billion by 2030, taking into account assumptions for V-shaped economic conditions.

• Profiles and generic drugs revenue forecasts from 2020-2030 of these selected leading companies:

• Abbott

• Apotex

Aspen

• Dr. Reddy's Laboratories Limited

• Fresenius Kabi

• Mylan

• Novartis

• Pfizer

• Sanofi

• Sun Pharma

• Teva

• Taisho Pharmaceutical Holdings Co Ltd

• ASKA Pharmaceutical Co., Ltd.

• H. Lundbeck A/S

• Roche Holding

• Qualitative analysis of the generic drugs market:

• SWOT Analysis of the generic drugs market

• Porter's Five Forces Analysis of the generic drugs market

• Discussion on factors that drive and restrain the generic drugs market

• Key Questions Answered by This Report:

• How is the global market for generic drugs evolving?

• What are the major factors driving and restraining the generic drugs market dynamics?

• What were the market shares of the leading national markets in the global generic drugs market in 2019?

• How will each of these national markets grow over the forecast period and how much revenue will these markets account for by 2030?

• How will the market shares for each of the national markets develop from 2020 to 2030?

• Which particular national markets will be the main drivers of growth in the global market for generics from 2020 to 2030?

• How will political and regulatory factors influence the regional markets and submarkets?

• What are the predictions for partnerships, consolidation for existing players and the potential prospects for new market entrants?

• How will the industry sector evolve as legislations around patents and patent expiries change during the period between 2020 and 2030?

To request a report overview of this report please email contactus@visiongain.com or refer to our website: https://www.visiongain.com/report/generic-drugs-market-report-2020-2030/#download_sampe_div

Did you know that we also offer a report add-on service? Email contactus@visiongain.com to discuss any customized research needs you may have.

Companies covered in the report include:

Abbott Laboratories

AbbVie

Able Labs

Aché

Actavis

Agência Nacional de Vigilância Sanitária

Agila Specialties

Akron Pharmaceuticals

Alkem Laboratories

Allergan

American Pharmaceutical Association

Amgen

Anterios

Arcolab

ASKA Pharmaceuticals

Aspen

AstraZeneca

Aurobindo

Auspex Pharmaceuticals

Baxter International

Bayer

Bedford Laboratories

Bergamo

Biocon

Bioniche Pharma Holdings

Blue Cross Blue Shield Association

British Generic Manufacturers Association

Caisse Nationale de l'Assurance Maladie

Caraco

Center for Drug Evaluation and Research

Centers for Medicare and Medicaid

CFR Pharmaceuticals

Cipla

Claris

Competition Commission of India

Daiichi Sankyo

Dalim BioTech

Dr. Reddy's Laboratories

Ebewe Pharma

Eden Biopharm Group

Elder Pharmaceuticals

Eli Lilly Company

Elyson Pharmaceuticals

EMS Sigma Pharma

Eon Labs

Eurofarma Laboratories

European Generic Medicines Association

European Medicines Agency

Farmacias Similares

Filaxis

Fougera Pharmaceuticals

Fresenius Kabi

Fuji Pharma

Gavis Pharmaceuticals

GlaxoSmithKline (GSK)

Grupo Sanborns

Grupo Uriach

Hexal

Hisun-Pfizer Pharmaceuticals

Hospira Healthcare India Private Limited

Ilsung Pharmaceuticals

Imperial Credit Private Limited

InnoPharma

Italian Generics Association, Assogenerici

Itero Biopharmaceuticals

Janssen Pharmaceuticals

Johnson & Johnson

King Pharmaceuticals

Kmart

KMS Pharmaceutical

Kowa Pharmaceuticals

Labesfal

Laboratorio Sanderso

Laboratorios Best

Lek

List of Organisations Mentioned in the Report

Lundbeck

Lupin Pharmaceuticals

Mayne Pharma

Meda AB

Medical Technology Association of Australia

Medley

Merck KGaA's

Ministry of Health, Labour and Welfare

Momenta

MSD

Mylan

Natco

National Health Service

National Health Surveillance Agency

Nexus Pharmaceuticals

Nichi-Iko

Nippon Chemiphar

Novartis (Sandoz)

Novo Nordisk

Orchid Chemicals & Pharmaceuticals

Oriel Therapeutics

Patriot Pharma

Pfizer

Pharmaceuticals and Medical Devices Agency

Pharmacia

Piramal

PT Ethica Industry Farmasi

PT Soho Global Health

Ranbaxy

Ratiopharm

Ribbon

Rimsa

Roche

Sabex

Sandoz

Sanofi

Sawai Pharmaceuticals

Servicio Sanitario Nazionale

Servier

Sigma Pharmaceuticals

Solvay Pharmaceuticals

St. Jude Medical

STADA Arzneimittel

Strides Arcolab

Sun Pharma

Synthélabo

Taisho Pharmaceutical

Taiyo Pharmaceuticals

Takeda Pharmaceutical Company Limited

Target

Teuto Brasileiro

Teva

Torrent Pharmaceuticals

Towa

US Federal Trade Comission

US Generic Pharmaceutical Association

Walmart

Warner Chilcott

Watson Pharmaceuticals

Werner – Lambert

Wockhardt

Wyeth

Zentiva

Zhejiang Hisun Pharmaceutical

Zydus Cadila

To see a report overview please e-mail contactus@visiongain.com

RELATED REPORTS:

Top Generic Drug Producers Market Forecast 2019-2029

Global Anti-Obesity Drugs Market Forecast 2020-2030

Global Antidepressant and Anti-Anxiety Drugs Market 2019-2029

Global Antibacterial Drugs Market 2019-2029

Global OTC Pharmaceutical Market Forecast 2019-2029

Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg

Voltar noticias em Inglês